Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Verona Pharma Plc ADR (NQ: VRNA ) 15.71 UNCHANGED Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,779 Open 15.71 Bid (Size) 15.77 (1) Ask (Size) 15.90 (1) Prev. Close 15.71 Today's Range 15.71 - 15.71 52wk Range 11.39 - 23.07 Shares Outstanding 480,291,822 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product June 27, 2024 The FDA has approved Verona Pharma's Ohtuvayre (ensifentrine) as maintenance treatment of chronic obstructive pulmonary disease in adults. The drug could generate $3.6 billion in peak sales. Via Benzinga Exposures Product Safety 10 Health Care Stocks Whale Activity In Today's Session June 25, 2024 Via Benzinga Performance YTD -16.48% -16.48% 1 Month +29.83% +29.83% 3 Month -5.02% -5.02% 6 Month -21.61% -21.61% 1 Year -23.92% -23.92% More News Read More 5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More June 24, 2024 Via Benzinga Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday June 13, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Via Benzinga Earnings Preview For Verona Pharma February 28, 2024 Via Benzinga Expert Ratings for Verona Pharma September 01, 2023 Via Benzinga Earnings Scheduled For August 3, 2023 August 03, 2023 Via Benzinga Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks June 13, 2024 Via Investor's Business Daily VRNA Stock Earnings: Verona Pharma Misses EPS for Q1 2024 May 09, 2024 Via InvestorPlace 3 Healthcare Stocks That Have Outperformed Nvidia Since 2022 March 01, 2024 Via The Motley Fool 3 Stocks That Could Be Monster Winners in 2024 December 30, 2023 Via The Motley Fool Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves December 29, 2023 Via Benzinga 4 Analysts Have This to Say About Verona Pharma March 13, 2023 Via Benzinga Earnings Preview For Verona Pharma March 06, 2023 Via Benzinga If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today December 30, 2022 Via Benzinga Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 26, 2023 Via Benzinga Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal April 08, 2023 Via Talk Markets Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday March 20, 2023 Via Benzinga Earnings Scheduled For November 2, 2023 November 02, 2023 Via Benzinga Earnings Scheduled For May 9, 2023 May 09, 2023 Via Benzinga 7 Biotech Stocks That Could Be the Next Big Thing March 15, 2023 Via InvestorPlace PDS Biotechnology, Pulmonx, Tesla And Some Other Big Stocks Moving Lower On Tuesday January 03, 2023 Via Benzinga Why These 7 Healthcare Stocks Could Soar in 2023 January 02, 2023 Via InvestorPlace 20 Favorite Biotech & Medical Stocks For 2023 December 28, 2022 Via Talk Markets Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
